Foresite Capital Management VI LLC
data from 30/09/2025
Capitalization
$ 258.867 M
45.53 %
Performance
$ 35.866 M
25.23 %
| Date | Ticket | Name | Weight | Capitalization | Share number | First added | Performance ($) | Performance (%) |
|---|---|---|---|---|---|---|---|---|
| 2025/09/30 | CGON | CG Oncology, Inc. | 34.57% | 89.481 M $ | 2221474 | 2024/12/31 | 31.723 M $ | 54.92 % |
| 2025/09/30 | RAPT | RAPT Therapeutics, Inc. | 15.57% | 40.297 M $ | 1562500 | 2025/06/30 | 27.797 M $ | 222.38 % |
| 2025/09/30 | CNTA | Centessa Pharmaceuticals plc | 12.31% | 31.865 M $ | 1314019 | 2024/12/31 | 13.925 M $ | 84.55 % |
| 2025/09/30 | VSTM | Verastem, Inc. | 8.92% | 23.092 M $ | 2615120 | 2025/06/30 | 5.974 M $ | 112.77 % |
| 2025/09/30 | ALMS | ALUMIS INC. | 6.55% | 16.948 M $ | 4247670 | 2024/12/31 | 4.205 M $ | 33.00 % |
| 2025/09/30 | DNLI | Denali Therapeutics Inc. | 5.61% | 14.520 M $ | 1000000 | 2025/09/30 | 0.000 $ | 0.00 % |
| 2025/09/30 | CRVS | Corvus Pharmaceuticals, Inc. | 4.93% | 12.759 M $ | 1731233 | 2024/12/31 | 5.834 M $ | 84.25 % |
| 2025/09/30 | AKRO | Akero Therapeutics, Inc. | 4.49% | 11.628 M $ | 244900 | 2024/12/31 | -1.440 M $ | -11.02 % |
| 2025/09/30 | KYMR | Kymera Therapeutics, Inc. | 3.20% | 8.282 M $ | 146332 | 2024/12/31 | 1.896 M $ | 29.70 % |
| 2025/09/30 | HNGE | Hinge Health, Inc. | 2.56% | 6.626 M $ | 135000 | 2025/06/30 | -360.450 K $ | -5.16 % |
| 2025/09/30 | RNA | Avidity Biosciences, Inc. | 0.67% | 1.743 M $ | 40000 | 2025/06/30 | 606.800 K $ | 53.42 % |
| 2025/09/30 | CASI | CASI Pharmaceuticals, Inc. | 0.63% | 1.627 M $ | 979956 | 2024/12/31 | 377.818 K $ | 40.68 % |
| 2025/09/30 | VRDN | Viridian Therapeutics, Inc | 0.00% | 0.000 $ | 0 | 2024/12/31 | 0.000 $ | 0.00 % |
| 2025/09/30 | CGEM | Cullinan Therapeutics Inc | 0.00% | 0.000 $ | 0 | 2024/12/31 | 0.000 $ | 0.00 % |
| 2025/09/30 | EWTX | Edgewise Therapeutics Inc | 0.00% | 0.000 $ | 0 | 2024/12/31 | 0.000 $ | 0.00 % |
| 2025/09/30 | BCAX | Bicara Therapeutics Inc | 0.00% | 0.000 $ | 0 | 2024/12/31 | 0.000 $ | 0.00 % |
| 2025/09/30 | IDYA | Ideaya Biosciences Inc | 0.00% | 0.000 $ | 0 | 2025/06/30 | 0.000 $ | 0.00 % |
| 2025/09/30 | SYRE | Spyre Therapeutics Inc | 0.00% | 0.000 $ | 0 | 2025/06/30 | 0.000 $ | 0.00 % |
| 2025/09/30 | GPCR | Structure Therapeutics Inc | 0.00% | 0.000 $ | 0 | 2024/12/31 | 0.000 $ | 0.00 % |
| 2025/09/30 | XENE | Xenon Pharmaceuticals Inc | 0.00% | 0.000 $ | 0 | 2025/06/30 | 0.000 $ | 0.00 % |
| 2025/09/30 | ALLO | Allogene Therapeutics Inc | 0.00% | 0.000 $ | 0 | 2024/12/31 | 0.000 $ | 0.00 % |